Subscribe To
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
Combined Company to Trade on Nasdaq Under Ticker “TRML”Talaris Announces 1-for-10 Reverse Stock Split of Common Stock BOSTON, Oct. 17, 2023 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS) (“Talaris”) today announced the results of the special meeting of its stockholders held on October 17, 2023. At the special meeting, Talaris’ stockholders voted in favor […] The post Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio appeared first on ForexTV...
Read More
Posted: Oct 17 2023, 21:47
Author Name: forextv
Views: 092027